GLP-1 pegylated compounds

Details for Australian Patent Application No. 2006247734 (hide)

Owner Eli Lilly and Company

Inventors Glaesner, Wolfgang; Millican, Rohn Lee Junior; Vick, Andrew Mark; Zhang, Lianshan; Mayer, John Philip

Agent Spruson & Ferguson

Pub. Number AU-B-2006247734 (Modified Examination)

PCT Pub. Number WO2006/124529

Priority 60/680,688 13.05.05 US

Filing date 11 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 23 June 2011

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/124529 Priority application(s): WO2006/124529

23 June 2011 Application Accepted

  Published as AU-B-2006247734 (Modified Examination)

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006247738-Substituted N-arylpyrrolidines as selective androgen receptor modulators

2006247733-Multicompartment evacuable storage bag